VEGF-C, human recombinant protein
mRNA synthesis
In vitro transcription of capped mRNA with modified nucleotides and Poly(A) tail
Tyramide Signal Amplification (TSA)
TSA (Tyramide Signal Amplification), used for signal amplification of ISH, IHC and IC etc.
Phos Binding Reagent Acrylamide
Separation of phosphorylated and non-phosphorylated proteins without phospho-specific antibody
Cell Counting Kit-8 (CCK-8)
A convenient and sensitive way for cell proliferation assay and cytotoxicity assay
SYBR Safe DNA Gel Stain
Safe and sensitive stain for visualization of DNA or RNA in agarose or acrylamide gels.
Inhibitor Cocktails
Protect the integrity of proteins from multiple proteases and phosphatases for different applications.
The recombinant Vascular Endothelial Growth Factor-C (VEGF-C) is a 125 amino acid protein that lacks the N-terminal signal peptide. Human VEGF-C has about 85% homology with murine VEGF-C. VEGF-C that combined with bone marrow stromal cell transplantation could enhance the therapeutic effect of each other.
| DTested by the stimulation of VEGF-R3 phosphorylation in cells transfected with VEGF-R3. | ||||||
| Specific activity | > 200 ng/ml. | |||||
Quality Control & DataSheet
- View current batch:
-
Purity: ≥90%, by SDS-PAGE and HPLC.
Endotoxin Level:<0.1 ng/μg
| Gene ID: | 7424 | Accession #: | Q6FH59 |
| Alternate Names: | Vascular Endothelial Growth Factor-C, VEGFC | ||
| Source: | Escherichia Coli. | M.Wt: | 15-16 kDa |
| Appearance: | Lyophilized powder | Storage: | Store at -20°C |
| Formulation: | Sterile filtered and lyophilized with no additives. | ||
| Solubility: | Reconstitute in 0.1% acetic acid to a concentration of 0.1-1.0 mg/ml. | ||
| Shipping Condition: | Blue ice. | Handling: | Centrifuge the vial prior to opening. |
| Usage: | For Research Use Only! Not to be used in humans. | ||